{
    "code": "70000035",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=70000035",
    "time": "2022-06-17 07:11:17",
    "許可證字號": "衛部罕藥輸字第000035號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/08\/25",
    "發證日期": "105\/08\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA07000003507",
    "中文品名": "柯珮鬆注射液40毫克",
    "英文品名": "Copaxone 40mg\/ml, Pre-Filled syringe for Injection",
    "適應症": "用於復發型多發性硬化症，以減少復發型多發性硬化症病人的復發頻率。",
    "劑型": "27D注射液劑",
    "包裝": "1ml注射針筒(附針) 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "新使用劑量及新單位含量",
    "監視期限": "",
    "主成分略述": "GLATIRAMER ACETATE",
    "限制項目": "02輸　入",
    "申請商名稱": "620102K944  香港商艾維斯有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝東路二段116號10樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIL0011100  TEVA PHARMACEUTICAL INDUSTRIES LTD.",
            "製造廠廠址": "18, ELI HURVITZ STREET, KFAR SABA 4410202, ISRAEL",
            "製造廠公司地址": "",
            "製造廠國別": "ISRAEL",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200043510",
            "成分名稱": "GLATIRAMER ACETATE",
            "含量描述": "",
            "含量": "40.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Copaxone 40mg_syringe_實體照片_201809-107-09-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000035&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Copaxone 40mg_TW_PIL_CLN_給使用者資訊_202102-110-02-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000035&Seq=007&Type=9"
        },
        {
            "title": "64453_Copaxone 40mg_中文仿單_202101-110-02-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000035&Seq=006&Type=9"
        },
        {
            "title": "020000350006_201609_Carton-105-09-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000035&Seq=003&Type=8"
        },
        {
            "title": "020000350002-201609-Blister-105-09-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000035&Seq=002&Type=8"
        },
        {
            "title": "020000350001-201609-Label-105-09-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000035&Seq=001&Type=8"
        }
    ]
}